Status
Conditions
Treatments
About
Chronic postoperative pain is an entity that is usually neglected by anesthetists, but several studies show that the choice of anesthetic technique may interfere with this prevalence. Esmolol is a selective beta-blocker of ultra fast duration that has been studied as a perioperative venous adjuvant with antihyperalgesic and opioid sparing action. The investigators ventured the possibility of this anti-hyperalgesic effect attenuating the chronic pain syndrome post-mastectomy.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
66 participants in 2 patient groups
Loading...
Central trial contact
Fabricio T Mendonça, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal